Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | 0 | 15,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 15,000 |
| Operating Expenses | 79,773 | 68,472 | 53,790 | 54,653 | 45,777 |
| Operating Income | -79,773 | -68,472 | -53,790 | -54,653 | -30,777 |
| Interest Expense | 2,731 | 2,808 | 2,890 | 2,884 | 2,877 |
| Other Income | 4,113 | 4,595 | 1,955 | 7,972 | 8,916 |
| Pre-tax Income | -78,391 | -66,685 | -54,725 | -49,565 | -24,738 |
| Income Tax | 850 | -522 | 166 | 778 | 1,397 |
| Net Income Continuous | -79,241 | -66,163 | -54,891 | -50,343 | -26,135 |
| Net Income | $-79,241 | $-66,163 | $-54,891 | $-50,343 | $-26,135 |
| EPS Basic Total Ops | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 |
| EPS Basic Continuous Ops | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 |
| EPS Diluted Total Ops | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 |
| EPS Diluted Continuous Ops | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.48 | -0.41 | -0.38 | -0.20 |
| EBITDA(a) | $-79,189 | $-67,952 | $-53,282 | $-54,134 | $-30,248 |